Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Merck
McKesson
AstraZeneca
Harvard Business School
Johnson and Johnson
Boehringer Ingelheim

Last Updated: May 27, 2022

Drug Sales Trends for ESOMEPRAZOLE


✉ Email this page to a colleague

« Back to Dashboard

Payment Methods and Pharmacy Types for ESOMEPRAZOLE (2019)

Revenues by Pharmacy Type

Pharmacy Type Revenues
INSIDE ANOTHER STORE $4,596,331
INSIDE HMO/CLINIC/HOSPITAL $4,543,660
[disabled in preview] $123,261,335
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
INSIDE ANOTHER STORE 3,474
INSIDE HMO/CLINIC/HOSPITAL 75,755
[disabled in preview] 139,743
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICARE $18,349,819
OTHER FEDERAL $4,543,660
[disabled in preview] $109,507,846
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for ESOMEPRAZOLE
Drug Units Sold Trends for ESOMEPRAZOLE

Annual Sales Revenues and Units Sold for ESOMEPRAZOLE

These sales figures are drawn from a US national survey of drug expenditures

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKesson
Boehringer Ingelheim
Express Scripts
AstraZeneca
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.